Company / Shareholders' Equity
TransMedics Group, Inc. Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$473.1M
FY2025
5-year range
$54.6M / $473.1M
FY2021-FY2025
Trend
+107.0%
vs FY2024
Sector context
#108 of 161
Health Care
What the data says
At $473M, TransMedics Group, Inc.'s shareholders' equity ranks #108 of 161 in the Health Care sector. Shareholders' Equity has increased for 4 consecutive years, from $55M in FY2021 to $473M in FY2025.
Based on SEC 10-K filings.
$473M in FY2025 with a 5-year CAGR of +54.0%.
Improved from $137M to $473M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +65.8%
- 5-Year CAGR
- +54.0%
- 10-Year CAGR
- -
Sector benchmark
#108 of 161 in Health CareTop 67% of 161This company $473.1M Sector average $5.1B
▼
-90.7% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s shareholders' equity has grown for 4 consecutive years.
- 5-year CAGR of +54.0%, indicating consistent growth.
- In FY2025, shareholders' equity increased 107.0% year-over-year.
- Ranks #108 out of 161 companies in the Health Care sector.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $473.1M | +107.0% |
| FY2024 | $228.6M | +66.6% |
| FY2023 | $137.2M | +32.1% |
| FY2022 | $103.9M | +90.1% |
| FY2021 | $54.6M | +0.0% |
| FY2020 | $54.6M | +128.4% |
| FY2019 | -$192.2M | +0.0% |
| FY2018 | -$192.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026